10-Q Filing

ENZON PHARMACEUTICALS, INC. CIK: 727510 Q2 2014

Filing Information

Form Type	10-Q
Accession Number	`0001144204-14-048065`
Period End Date	20140630
Filing Date	20140808
Fiscal Year	2014
Fiscal Period	Q2
XBRL Instance	enzn-20140630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 50 Income Statement 97 Cash Flow Statement 48

Balance Sheet 50 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$77.35M	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$6.52M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$11.46M	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$21.48M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$511.00K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$424.00K	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$90.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Total assets	`Assets`	$7.12M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Total assets	`Assets`	$21.90M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	44.13M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	44.09M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	44.09M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	44.13M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$257.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$93.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$539.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$1.22M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.31M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$796.00K	USD	Point-in-time
Accrued rent liability	`AccruedRentNoncurrent`	$467.00K	USD	Point-in-time
Accrued rent liability	`AccruedRentNoncurrent`	$558.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$1.87M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.26M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock - $.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at June 30, 2014 and December 31, 2013	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock - $.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at June 30, 2014 and December 31, 2013	`PreferredStockValue`	-	USD	Point-in-time
Common stock - $.01 par value, authorized 170,000,000 shares; issued and outstanding 44,125,410 shares at June 30, 2014 and 44,085,870 shares at December 31, 2013	`CommonStockValue`	$441.00K	USD	Point-in-time
Common stock - $.01 par value, authorized 170,000,000 shares; issued and outstanding 44,125,410 shares at June 30, 2014 and 44,085,870 shares at December 31, 2013	`CommonStockValue`	$441.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$134.51M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$134.49M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-129.70M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-114.29M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$5.25M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$20.64M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$7.12M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$21.90M	USD	Point-in-time

Income Statement 97 line items

Line Item	Tag	Value	Unit	Period
Royalties	`RoyaltyRevenue`	$8.04M	USD	1 Quarter
Royalties	`RoyaltyRevenue`	$7.74M	USD	1 Quarter
Royalties	`RoyaltyRevenue`	$17.61M	USD	2 Qtrs
Royalties	`RoyaltyRevenue`	$16.68M	USD	2 Qtrs
Miscellaneous income	`OtherSalesRevenueNet`	$63.00K	USD	2 Qtrs
Miscellaneous income	`OtherSalesRevenueNet`	$631.00K	USD	2 Qtrs
Miscellaneous income	`OtherSalesRevenueNet`	$31.00K	USD	1 Quarter
Miscellaneous income	`OtherSalesRevenueNet`	$12.00K	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$7.77M	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$18.24M	USD	2 Qtrs
Total revenues	`SalesRevenueNet`	$8.06M	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$16.74M	USD	2 Qtrs
Research and development - pipeline	`ResearchAndDevelopmentExpense`	-	USD	2 Qtrs
Research and development - pipeline	`ResearchAndDevelopmentExpense`	$1.87M	USD	2 Qtrs
Research and development - pipeline	`ResearchAndDevelopmentExpense`	$294.00K	USD	1 Quarter
Research and development - pipeline	`ResearchAndDevelopmentExpense`	-	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$836.00K	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$2.40M	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$5.35M	USD	2 Qtrs
General and administrative	`OtherGeneralAndAdministrativeExpense`	$1.34M	USD	2 Qtrs
Restructuring charges	`RestructuringCharges`	$2.97M	USD	2 Qtrs
Restructuring charges	`RestructuringCharges`	-	USD	1 Quarter
Restructuring charges	`RestructuringCharges`	-	USD	1 Quarter
Restructuring charges	`RestructuringCharges`	$464.00K	USD	1 Quarter
Restructuring charges	`RestructuringCharges`	-	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$10.19M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$1.34M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$3.16M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$836.00K	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$15.40M	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$6.93M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$4.90M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$8.05M	USD	2 Qtrs
Investment income, net	`InvestmentIncomeNet`	$530.00K	USD	2 Qtrs
Investment income, net	`InvestmentIncomeNet`	-	USD	2 Qtrs
Investment income, net	`InvestmentIncomeNet`	$103.00K	USD	1 Quarter
Investment income, net	`InvestmentIncomeNet`	-	USD	1 Quarter
Interest expense	`InterestExpense`	$850.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$2.12M	USD	2 Qtrs
Interest expense	`InterestExpense`	-	USD	2 Qtrs
Interest expense	`InterestExpense`	-	USD	1 Quarter
Other, net	`OtherNonoperatingIncomeExpense`	$646.00K	USD	1 Quarter
Other, net	`OtherNonoperatingIncomeExpense`	$61.00K	USD	2 Qtrs
Other, net	`OtherNonoperatingIncomeExpense`	$-48.00K	USD	1 Quarter
Other, net	`OtherNonoperatingIncomeExpense`	$866.00K	USD	2 Qtrs
Total other (expense)	`NonOperatingIncomeExpenseIncludingInterestExpense`	$-48.00K	USD	1 Quarter
Total other (expense)	`NonOperatingIncomeExpenseIncludingInterestExpense`	$61.00K	USD	2 Qtrs
Total other (expense)	`NonOperatingIncomeExpenseIncludingInterestExpense`	$-101.00K	USD	1 Quarter
Total other (expense)	`NonOperatingIncomeExpenseIncludingInterestExpense`	$-728.00K	USD	2 Qtrs
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$7.32M	USD	2 Qtrs
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$6.88M	USD	1 Quarter
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$4.80M	USD	1 Quarter
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$15.46M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$55.00K	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$80.00K	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$213.00K	USD	2 Qtrs
Net income	`NetIncomeLoss`	$4.72M	USD	1 Quarter
Net income	`NetIncomeLoss`	$6.88M	USD	1 Quarter
Net income	`NetIncomeLoss`	$7.11M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$15.40M	USD	2 Qtrs
Unrealized holding gains (losses) arising during period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	-	USD	1 Quarter
Unrealized holding gains (losses) arising during period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	-	USD	2 Qtrs
Unrealized holding gains (losses) arising during period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$234.00K	USD	2 Qtrs
Unrealized holding gains (losses) arising during period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-3.00K	USD	1 Quarter
Reclassification adjustment for realized (gains) on sales included in net income	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	-	USD	2 Qtrs
Reclassification adjustment for realized (gains) on sales included in net income	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	-	USD	1 Quarter
Reclassification adjustment for realized (gains) on sales included in net income	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$320.00K	USD	2 Qtrs
Reclassification adjustment for realized (gains) on sales included in net income	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$39.00K	USD	1 Quarter
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-42.00K	USD	1 Quarter
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-86.00K	USD	2 Qtrs
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	-	USD	1 Quarter
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	-	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$7.02M	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$6.88M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$15.40M	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$4.68M	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.11	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.16	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.16	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.35	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.14	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.09	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.16	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.35	USD	2 Qtrs
Weighted-average shares - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	43.73M	shares	1 Quarter
Weighted-average shares - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	43.71M	shares	2 Qtrs
Weighted-average shares - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	44.11M	shares	1 Quarter
Weighted-average shares - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	44.10M	shares	2 Qtrs
Weighted-average shares - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	58.20M	shares	2 Qtrs
Weighted-average shares - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	44.25M	shares	1 Quarter
Weighted-average shares - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	55.27M	shares	1 Quarter
Weighted-average shares - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	44.26M	shares	2 Qtrs
Special cash dividend paid per common share (in dollars per share)	`CommonStockDividendsPerShareCashPaid`	$1.60	USD	2 Qtrs
Special cash dividend paid per common share (in dollars per share)	`CommonStockDividendsPerShareCashPaid`	$1.60	USD	1 Quarter
Special cash dividend paid per common share (in dollars per share)	`CommonStockDividendsPerShareCashPaid`	-	USD	2 Qtrs
Special cash dividend paid per common share (in dollars per share)	`CommonStockDividendsPerShareCashPaid`	-	USD	1 Quarter

Cash Flow Statement 48 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$4.72M	USD	1 Quarter
Net income	`NetIncomeLoss`	$6.88M	USD	1 Quarter
Net income	`NetIncomeLoss`	$7.11M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$15.40M	USD	2 Qtrs
Depreciation	`DepreciationAndAmortization`	$159.00K	USD	2 Qtrs
Depreciation	`DepreciationAndAmortization`	-	USD	2 Qtrs
Amortization and write-off of debt issuance costs	`AmortizationOfFinancingCosts`	$193.00K	USD	2 Qtrs
Amortization and write-off of debt issuance costs	`AmortizationOfFinancingCosts`	-	USD	2 Qtrs
Stock-based compensation and employee purchase plan discount	`ShareBasedCompensation`	$-366.00K	USD	2 Qtrs
Stock-based compensation and employee purchase plan discount	`ShareBasedCompensation`	-	USD	2 Qtrs
Loss on sales of marketable securities	`MarketableSecuritiesGainLoss`	$320.00K	USD	2 Qtrs
Loss on sales of marketable securities	`MarketableSecuritiesGainLoss`	-	USD	2 Qtrs
Amortization of purchase premium on marketable securities	`AmortizationOfPurchasePremiumOnMarketableSecurities`	$731.00K	USD	2 Qtrs
Amortization of purchase premium on marketable securities	`AmortizationOfPurchasePremiumOnMarketableSecurities`	-	USD	2 Qtrs
Gain on sale of assets	`GainLossOnDispositionOfAssets`	$60.00K	USD	2 Qtrs
Gain on sale of assets	`GainLossOnDispositionOfAssets`	$865.00K	USD	2 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$3.41M	USD	2 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$516.00K	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$3.23M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$14.83M	USD	2 Qtrs
Proceeds from sale of assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$152.00K	USD	2 Qtrs
Proceeds from sale of assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$942.00K	USD	2 Qtrs
Proceeds from sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$115.89M	USD	2 Qtrs
Proceeds from sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	-	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$116.84M	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$152.00K	USD	2 Qtrs
Common stock dividend	`PaymentsOfDividendsCommonStock`	-	USD	2 Qtrs
Common stock dividend	`PaymentsOfDividendsCommonStock`	$69.97M	USD	2 Qtrs
Retirement of notes payable	`RepaymentsOfNotesPayable`	-	USD	2 Qtrs
Retirement of notes payable	`RepaymentsOfNotesPayable`	$115.85M	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	-	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$12.00K	USD	2 Qtrs
Withholding taxes - stock based compensation	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$123.00K	USD	2 Qtrs
Withholding taxes - stock based compensation	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$22.00K	USD	2 Qtrs
Withdrawals/proceeds from employee stock purchase plan	`ProceedsFromStockPlans`	$-33.00K	USD	2 Qtrs
Withdrawals/proceeds from employee stock purchase plan	`ProceedsFromStockPlans`	-	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-22.00K	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-185.96M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$14.96M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-65.89M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$77.35M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$6.52M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$11.46M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$21.48M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$77.35M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$6.52M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$11.46M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$21.48M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.